Effects of polycations on ion channels formed by neutral and negatively charged alamethicins.
The effects of the peptide polycations salmon protamine (M(r) = 4332, z = +21) and poly-L-lysine (M(r) approximately equal to 100,000, z approximately equal to +775) on ion channels formed by synthetic alamethicin Alm-F30 (one negative charge), natural Alm-F50 (neutral) and phosphorylated Alm-F50 (two negative charges) reconstituted in planar lipid bilayers have been studied at the single channel level. It was observed that both polycations in micromolar concentrations transiently block ion permeation through the channels formed by each alamethicin analogue, although in case of the neutral Alm-F50 to a significantly lesser extent. Poly-L-lysine showed to be more effective than protamine in blocking these channels. If either polycation is present in the cis-compartment, blockade occurs only at cis positive membrane voltages. At constant polycation concentration, dwell times in the blocked state increase when salt concentration is lowered, and decrease at acidic pH with an apparent pK of 4.8. Mean lifetime of blockade events shortens when membrane voltage is increased, which suggests that both polycations may permeate through the oligomeric alamethicin channels if conductance levels are > 2. We suggest that blockade is caused by electrostatic binding of a single polycation molecule to the C-terminal channel mouth; in case of Alm-F30, Glu18 has to be considered as the putative binding site. Our results provide further evidence for the barrel-stave model and a parallel orientation of dipole monomers in the channel aggregate, the C-termini facing the membrane side with the more positive membrane potential.
Rink
T
T
Department Cell Physiology, Ruhr-Universität Bochum, Germany.
Bartel
H
H
Jung
G
G
Bannwarth
W
W
Boheim
G
G
D000200:Action Potentials / Q000187:drug effects; D000408:Alamethicin / Q000737:chemistry / Q000494:pharmacology*; D000595:Amino Acid Sequence; D000818:Animals; D002412:Cations; D007473:Ion Channels / Q000187:drug effects*; D008051:Lipid Bilayers; D008969:Molecular Sequence Data; D011107:Polylysine / Q000494:pharmacology*; D011479:Protamines / Q000494:pharmacology*; D012474:Salmon
D002412:Cations; D007473:Ion Channels; D008051:Lipid Bilayers; D011479:Protamines; D011107:Polylysine; D000408:Alamethicin